Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Bone. 2011 Jun 25;49(4):644–652. doi: 10.1016/j.bone.2011.06.011

Figure 2.

Figure 2

(a) Percent cell death of differentiated RAW-osteoclasts and MC3T3-E1 osteoblasts on type I collagen (COL1), fibronectin (FN) and vitronectin (VN) without serum after treatment of GST, GST-PIIBNP and GST-mutant PIIBNP for 16 h. (b) Percent cell death of primary osteoclasts and osteoblasts. Columns represent mean ± S.D. of percent of trypan blue stained cells/ total cells in medium and on the plate. Each assay was performed in triplicate wells and three independent experiments. *indicates p<0.05 versus cells treated with 3 μM GST.